BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23668802)

  • 21. Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
    Zollner A; Schmiderer A; Reider SJ; Oberhuber G; Pfister A; Texler B; Watschinger C; Koch R; Effenberger M; Raine T; Tilg H; Moschen AR
    J Crohns Colitis; 2021 Jan; 15(1):43-54. PubMed ID: 32556317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic Evolution in Non-neoplastic IBD-Affected Colon.
    Olafsson S; McIntyre RE; Coorens T; Butler T; Jung H; Robinson PS; Lee-Six H; Sanders MA; Arestang K; Dawson C; Tripathi M; Strongili K; Hooks Y; Stratton MR; Parkes M; Martincorena I; Raine T; Campbell PJ; Anderson CA
    Cell; 2020 Aug; 182(3):672-684.e11. PubMed ID: 32697969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans.
    Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Gil MJ; Cienfuegos JA; Salvador J; Frühbeck G
    J Mol Med (Berl); 2009 Aug; 87(8):803-13. PubMed ID: 19466389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
    Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
    Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of protooncogene-encoded mRNA by colonic epithelial cells in inflammatory bowel disease.
    Alexander RJ; Panja A; Kaplan-Liss E; Mayer L; Raicht RF
    Dig Dis Sci; 1996 Apr; 41(4):660-9. PubMed ID: 8674385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.
    Auguet T; Terra X; Quintero Y; Martínez S; Manresa N; Porras JA; Aguilar C; Orellana-Gavaldà JM; Hernández M; Sabench F; Lucas A; Pellitero S; Del Castillo D; Richart C
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):119-24. PubMed ID: 23426707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn's disease.
    Thorsvik S; Bakke I; van Beelen Granlund A; Røyset ES; Damås JK; Østvik AE; Sandvik AK
    Cell Tissue Res; 2018 Nov; 374(2):339-348. PubMed ID: 29869714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.
    Babyatsky MW; Rossiter G; Podolsky DK
    Gastroenterology; 1996 Apr; 110(4):975-84. PubMed ID: 8613031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of endoplasmic reticulum stress in inflammatory bowel disease: a different implication for colonic and ileal disease?
    Bogaert S; De Vos M; Olievier K; Peeters H; Elewaut D; Lambrecht B; Pouliot P; Laukens D
    PLoS One; 2011; 6(10):e25589. PubMed ID: 22028783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
    Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
    Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of lipocalin-2 in liver regeneration.
    Kienzl-Wagner K; Moschen AR; Geiger S; Bichler A; Aigner F; Brandacher G; Pratschke J; Tilg H
    Liver Int; 2015 Apr; 35(4):1195-202. PubMed ID: 25040147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipocalin-2/neutrophil gelatinase-B associated lipocalin is strongly induced in hearts of rats with autoimmune myocarditis and in human myocarditis.
    Ding L; Hanawa H; Ota Y; Hasegawa G; Hao K; Asami F; Watanabe R; Yoshida T; Toba K; Yoshida K; Ogura M; Kodama M; Aizawa Y
    Circ J; 2010 Mar; 74(3):523-30. PubMed ID: 20057160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.
    Karlsen JR; Borregaard N; Cowland JB
    J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis.
    Saiz-Gonzalo G; Hanrahan N; Rossini V; Singh R; Ahern M; Kelleher M; Hill S; O'Sullivan R; Fanning A; Walsh PT; Hussey S; Shanahan F; Nally K; O'Driscoll CM; Melgar S
    Front Immunol; 2021; 12():655960. PubMed ID: 34394073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.
    Ferrer-Picón E; Dotti I; Corraliza AM; Mayorgas A; Esteller M; Perales JC; Ricart E; Masamunt MC; Carrasco A; Tristán E; Esteve M; Salas A
    Inflamm Bowel Dis; 2020 Jan; 26(1):43-55. PubMed ID: 31211831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.